13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 46 holding rows worth $149,212,987.
- Accession
- 0001104659-23-117779
- Filer
- CIK 1582844
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 46 entries on the cover page, a total value of $149,212,987 stated on the cover page (in dollars after the unit check, H1), rows summing to $149,212,987 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 3,827,926 | $12,096,246 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 244,484 | $9,300,171 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,849,402 | $8,951,106 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 4,485,000 | $7,669,350 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 344,571 | $7,649,476 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 550 | $7,580,650 | dollars as filed | call |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 362,000 | $7,417,380 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 205,377 | $7,132,743 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 138,198 | $6,492,542 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 702,093 | $6,403,088 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 418,000 | $6,232,380 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 121,022 | $6,169,702 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 129,000 | $4,952,310 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 297,035 | $4,312,948 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 270,319 | $3,635,791 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 126,500 | $3,543,265 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 224,339 | $3,441,360 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 122,341 | $3,366,824 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 94,000 | $2,795,560 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 555,260 | $2,792,958 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 150,000 | $2,566,500 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 300,128 | $2,398,023 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 551,010 | $2,385,873 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 323,349 | $2,092,068 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 153,007 | $1,889,636 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 15,500 | $1,878,910 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 230,000 | $1,869,900 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,000 | $1,766,000 | dollars as filed | call |
| 89BIO INC | 282559103 | COM | 1,000 | $1,523,000 | dollars as filed | call |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 103,600 | $1,415,176 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 146,500 | $1,312,640 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 718,739 | $934,361 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 121,692 | $833,590 | dollars as filed | |
| BRAINSTORM CELL THERAPEUTICS | 10501E201 | COM | 2,500 | $825,000 | dollars as filed | put |
| BIOMEA FUSION INC | 09077A106 | CMN | 39,935 | $549,506 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 11,300 | $512,568 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 32,800 | $506,432 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 354,166 | $488,749 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 310,000 | $409,200 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 121,300 | $320,232 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 5,000 | $252,100 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 13,300 | $213,864 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 19,500 | $156,975 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 99,607 | $126,501 | dollars as filed | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 27,500 | $41,250 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 90,832 | $9,083 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-117779 | this filing | 2023-11-14 | acceptance time not in the bulk data set |